Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jung Diagnostics is a medical technology company based in Hamburg, Germany, that provides automated, AI-driven analysis of neuroimaging data. The company specializes in the quantitative evaluation of brain MRI scans to assist in the early diagnosis and monitoring of neurodegenerative and neuroinflammatory diseases, such as Alzheimer’s disease and multiple sclerosis. By providing objective measurements of brain volume and lesion loads, Jung Diagnostics supports clinicians in making more precise diagnostic and therapeutic decisions. Their platform is used both in clinical practice and as a central imaging lab for pharmaceutical clinical trials.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jung Diagnostics.